Clinical Usefulness of a Database Predicting Drug-Drug Interactions Using Metabolic Information for Cytochrome P-450, as Evaluated From Dosage and Adverse Events of HMG-CoA Reductase Inhibitor Atorvastatin
Iryo Yakugaku (Japanese Journal of Pharmaceutical Health Care and Sciences)
doi 10.5649/jjphcs.32.1204
Full Text
Open PDFAbstract
Available in full text
Date
January 1, 2006
Authors
Publisher
Japanese Society of Pharmaceutical Health Care and Sciences